Commentary on “Neutrophil‐to‐lymphocyte and monocyte‐to‐lymphocyte ratios as inflammatory markers in the assessment of glycemic status in diabetic patients of Asir region” Authors: Mostafa Javanian, Majid Khalilizad, Mohammad Barary, Ebrahim Hejazian, Soheil Ebrahimpour Published: 2026 Dear Editor, Dera et al. 1 report that neutrophil‐to‐lymphocyte (NLR) and monocyte‐to‐lymphocyte (MLR) ratios differ across fasting‐glucose and HbA1c strata in 3545 Saudi adults, concluding that these indices “could serve as valuable indicators” of dysglycemia. Although the dataset is sizeable, several issues temper that inference. UNCONTROLLED CONFOUNDING The database lacks information on body mass index, infection status, use of anti‐diabetic or anti‐inflammatory medications, and chronic comorbidities, all of which are potent modifiers of leucocyte subsets and glycemic control. Attributing inflammatory changes solely to glucose without considering these variables risks residual bias. 2 STATISTICAL LIMITATIONS Both ratios are right‐skewed, yet the authors present means ± SD and apply one‐way ANOVA without transformation or non‐parametric tests. More than 100 subgroup comparisons were performed with no correction for multiplicity; several reported p values (e.g., adult‐women NLR p = 0.005) would not withstand false‐discovery adjustment. Crucially, no multivariable model assesses whether NLR/MLR remain associated with glycemia after simultaneous control for age and sex. DATA INTEGRITY AND CODING ERRORS Tab. 4 lists an implausible mean MLR of 1.22 in pre‐diabetic adults (≈6‐fold higher than neighboring cells) and mislabels fasting glucose ≥126 mg/dL as “hemoglobin.” Such transcription errors raise concern about duplicate encounters or miscoded values across 2021–2023. Clarifying that each participant contributed a single record and that extreme outliers were managed a priori would enhance credibility. TIMING OF BLOOD SAMPLING NLR can rise within hours after acute stress and fall quickly thereafter. Best practice is to document the interval between presentation and venipuncture and to exclude samples drawn during intercurrent illness. 3 The manuscript provides no such detail, risking differential misclassification. OVER‐INTERPRETATION OF CLINICAL UTILITY No receiver‐operating‐characteristic curves, cut‐offs, or prospective validation are provided. Recent studies have shown that composite indices, such as the systemic immune‐inflammation index and the platelet‐to‐lymphocyte ratio, outperform single ratios in identifying poor glycemic control. 4 , 5 Prospective analyses incorporating these markers and essential covariates are required before recommending NLR/MLR to clinicians. In summary, the reported associations are hypothesis‐generating rather than practice‐changing. Addressing the methodological and analytical gaps outlined above would greatly strengthen future research on inexpensive inflammatory biomarkers in diabetes. AUTHOR CONTRIBUTIONS Mostafa Javanian: Investigation; supervision; writing – original draft. Majid Khalilizad: Investigation; writing – original draft. Mohammad Barary: Investigation; writing – original draft; writing – review and editing. Ebrahim Hejazian: Investigation; writing – original draft. Soheil Ebrahimpour: Investigation; supervision; writing – original draft. FUNDING INFORMATION The authors have nothing to report. CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. ETHICS STATEMENT The authors have nothing to report.